News Daily News CVD Still the Leading Cause of Death and Disease Globally Michael O'Riordan September 24, 2025
News Conference News AHA 2024 ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery Yael L. Maxwell November 17, 2024
News Daily News TAVI Explantation Remains a Risky Proposition, Two New Studies Show Michael O'Riordan April 27, 2023
News Daily News Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest Michael O'Riordan October 20, 2022
News Daily News EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management L.A. McKeown September 22, 2021
News Conference News TCT 2020 Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains Todd Neale October 16, 2020
News Daily News Meta-analysis Supports Surgical LAA Occlusion During Cardiac Surgery, but Flaws Found Todd Neale August 16, 2019
News Daily News Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific Shelley Wood July 20, 2018
News Conference News TVT 2017 Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10 Shelley Wood June 12, 2017
News Conference News ESC 2013 New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups Caitlin E. Cox September 03, 2013